Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

Clinical trial NCT06801119 · RECRUITING

Trial details

NCT number: NCT06801119
Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Scleroderma Rheumatoid Arthritis

Start date: 2025-03-16
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.